The inflammatory bowel disease (IBD) pipeline of Shanghai Lishan Biomedicine Co., Ltd. has completed all the preparatory work for the previous FDA application, and will carry out the IND application of FDA in November this year, fully opening a new c
On August 27, 2024, on the occasion of the first anniversary of the Joint Laboratory of Intelligent Microbiome jointly established by Lishan Biomedicine Co., Ltd. and Fudan University, Zhuang Kesing, director of Lishan Biological Advisory Committee,
Dr. Li Changqing Hello, it is a great pleasure to welcome you to Lishan. Today we have a short interview to talk about your views as a former FDA Senior medical reviewer on the clinical trials of viable drugs. Can you describe the specificity of the
First of all, I would like to welcome Dr. Du to Lishan. The comprehensive strategic cooperation between Lishan and Eglin is a new starting point, and we look forward to more achievements in the future. First of all, I would like to ask Dr. Du, how do
On May 30, 2024, Shanghai Lishan Biomedicine Co., Ltd. officially launched the preclinical study of the childhood autism (ASD) pipeline. Lishan Biology has completed a lot of basic theoretical work on intestinal bacteria LBP drug research for childre
First of all, take a deep breath several times and let the whole body relax more and more with each exhalation. We inhale and feel all the energy in the air infiltrating into our body from every pore to nourish the whole body. Exhale and feel the who
Shanghai Public Network Anbei 31011502402974